AJP - GI AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G74-G84, 2005. First published August 26, 2004; doi:10.1152/ajpgi.00258.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/G74    most recent
00258.2004v2
00258.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, T.
Right arrow Articles by Chiang, J. Y. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, T.
Right arrow Articles by Chiang, J. Y. L.

LIVER AND BILIARY TRACT

Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7{alpha}-hydroxylase gene transcription

Tiangang Li and John Y. L. Chiang

Department of Biochemistry and Molecular Pathology, Northeastern Ohio University College of Medicine, Rootstown, Ohio

Submitted 14 June 2004 ; accepted in final form 25 August 2004

Bile acids, steroids, and drugs activate steroid and xenobiotic receptor pregnane X receptor (PXR; NR1I2), which induces human cytochrome P4503A4 (CYP3A4) in drug metabolism and cholesterol 7{alpha}-hydroxylase (CYP7A1) in bile acid synthesis in the liver. Rifampicin, a human PXR agonist, inhibits bile acid synthesis and has been used to treat cholestatic diseases. The objective of this study is to elucidate the mechanism by which PXR inhibits CYP7A1 gene transcription. The mRNA expression levels of CYP7A1 and several nuclear receptors known to regulate the CYP7A1 gene were assayed in human primary hepatocytes by quantitative real-time PCR (Q-PCR). Rifampicin reduced CYP7A1 and small heterodimer partner (SHP; NR02B) mRNA expression suggesting that SHP was not involved in PXR inhibition of CYP7A1. Rifampicin inhibited CYP7A1 reporter activity and a PXR binding site was localized to the bile acid response element-I. Mammalian two-hybrid assays revealed that PXR interacted with hepatic nuclear factor 4{alpha} (HNF4{alpha}, NR2A1) and rifampicin was required. Coimmunoprecipitation assay confirmed PXR interaction with HNF4{alpha}. PXR also interacted with peroxisome proliferator-activated receptor {gamma} coactivator (PGC-1{alpha}), which interacted with HNF4{alpha} and induced CYP7A1 gene transcription. Rifampicin enhanced PXR interaction with HNF4{alpha} and reduced PGC-1{alpha} interaction with HNF4{alpha}. Chromatin immunoprecipitation assay showed that PXR, HNF4{alpha}, and PGC-1{alpha} bound to CYP7A1 chromatin, and rifampicin dissociated PGC-1{alpha} from chromatin. These results suggest that activation of PXR by rifampicin promotes PXR interaction with HNF4{alpha} and blocks PGC-1{alpha} activation with HNF4{alpha} and results in inhibition of CYP7A1 gene transcription. Rifampicin inhibition of bile acid synthesis may be a protective mechanism against drug and bile acid-induced cholestasis.

bile acid synthesis; gene regulation; nuclear receptors; peroxisome proliferator-activated receptor {gamma} coactivator



Address correspondence: J. Y. L. Chiang, Dept. of Biochemistry and Molecular Pathology, Northeastern Ohio Univ. College of Medicine, 4209 State Route 44, P.O. Box 95, Rootstown, OH 44272 (E-mail: jchiang{at}neoucom.edu)




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
T. Li, H. Ma, and J. Y. L. Chiang
TGF{beta}1, TNF{alpha}, and insulin signaling crosstalk in regulation of the rat cholesterol 7{alpha}-hydroxylase gene expression
J. Lipid Res., September 1, 2008; 49(9): 1981 - 1989.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
B. Ning, S. Dial, Y. Sun, J. Wang, J. Yang, and L. Guo
Systematic and Simultaneous Gene Profiling of 84 Drug-Metabolizing Genes in Primary Human Hepatocytes
J Biomol Screen, March 1, 2008; 13(3): 194 - 201.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-L. Fang, S. C. Strom, E. Ellis, Z. Duanmu, J. Fu, Z. Duniec-Dmuchowski, C. N. Falany, J. L. Falany, T. A. Kocarek, and M. Runge-Morris
Positive and Negative Regulation of Human Hepatic Hydroxysteroid Sulfotransferase (SULT2A1) Gene Transcription by Rifampicin: Roles of Hepatocyte Nuclear Factor 4{alpha} and Pregnane X Receptor
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 586 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Li, W. Chen, and J. Y. L. Chiang
PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine
J. Lipid Res., February 1, 2007; 48(2): 373 - 384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Zollner, M. Wagner, T. Moustafa, P. Fickert, D. Silbert, J. Gumhold, A. Fuchsbichler, E. Halilbasic, H. Denk, H.-U. Marschall, et al.
Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-{alpha}/beta in the adaptive response to bile acids
Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G923 - G932.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.